Weighing mainstream and alternative accounts…
Two lenses on the same evidence. Source weight and the primary source ratio show what each rests on.
Deeper threads worth pulling on next.
Investigated
NewsDerived from:“Nearly 30,000 people tested quit-smoking methods. One stood out”· ScienceDaily: Health & Medicine
Image: nhs.uk
Randomized-trial reviews generally find nicotine e-cigarettes produce higher six-month quit rates than patches or gum, with the latest Cochrane update estimating roughly four additional quitters per 100 people compared with nicotine replacement therapy. However, earlier meta-analysis evidence was low-certainty, and critics dispute whether current comparisons adequately capture harms, sustained abstinence, and real-world treatment effectiveness. Long-term vaping risks remain uncertain.
Two lenses on the same evidence. Source weight and the primary source ratio show what each rests on.
Lens adapted to this topic: Skeptical interpretation of the evidence
Critics argue that apparent superiority over patches or gum should not be treated as settled proof that e-cigarettes are the best cessation treatment in every setting. They point to low or very low certainty in some comparisons, possible differences in adherence and product use, continued nicotine dependence, and insufficient evidence about long-term harms. Some respiratory-health commentators reject e-cigarettes as a cessation treatment altogether.
Deeper threads worth pulling on next.